(Nanowerk News) Rapid, sensitive diagnosis of COVID-19 is essential for early treatment, contact tracing and reducing viral spread. However, some people infected with SARS-CoV-2 receive false-negative ...

Testing for the severe acute respiratory syndrome 2 (SAR-CoV-2) has progressed over the course of the current pandemic and is now widely available for adults and children who suspect they may have ...

Scientists from Hokkaido University have shown that an antigen-based test for quantifying SARS-CoV-2 in saliva samples is simple, rapid, and more conducive for mass-screening. More than a year into ...

You may have noticed that more and more people are testing positive for COVID-19 after using a rapid test to swab their throats. The trend took off on Twitter this past week, and unlike most of the ...

Biosensors are being used as a tool for detecting the presence of SARS-CoV-2 in patients and diagnosing COVID-19. Early and rapid detection of the disease will help manage the outbreak by curbing the ...

WALTHAM, Mass. & WATERTOWN, Mass.--(BUSINESS WIRE)--Rhinostics Inc. and Nexus Medical Labs recently received Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) for a ...

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) diagnosis is important for patients and public health to assess the levels of virus and infection risk. Due to the high need for SARS-CoV-2 ...

Basel, 26 February 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced it has been granted special approval by the German Federal Institute for Drugs and Medical Devices (BfArM) to offer the ...

QIAGEN N.V. QGEN recently announced the receipt of emergency use authorization (EUA) from the FDA for its QIAreach SARS CoV-2 Antigen Test. This rapid portable test is designed to address the ...